|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/00 | |
| A61K 38/20 | |||
| C07K 14/55 |
| (11) | Number of the document | 3134102 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15782644.7 |
| Date of filing the European patent application | 2015-04-24 | |
| (97) | Date of publication of the European application | 2017-03-01 |
| (45) | Date of publication and mention of the grant of the patent | 2019-07-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/027635 |
| Date | 2015-04-24 |
| (87) | Number | WO 2015/164815 |
| Date | 2015-10-29 |
| (30) | Number | Date | Country code |
| 201461983973 P | 2014-04-24 | US |
| (72) |
GARCIA, K., Christopher, US
MITRA, Suman, US
LEONARD, Warren, J., US
RING, Aaron, M., US
|
| (73) |
United States Department of Health and Human Services, Office of Technology Transfer, National Institutes of Health,
6011 Executive Boulevard, Suite 325 MSC 7660, Bethesda, MD 20892-7660,
US
The Board of Trustees of the Leland Stanford Junior University, Office of the General Counsel Building 170, Third Floor, Main Quad P.O. Box 20386, Stanford, CA 94305-2038, US |
| (54) | SUPERAGONISTS, PARTIAL AGONISTS AND ANTAGONISTS OF INTERLEUKIN-2 |
| SUPERAGONISTS, PARTIAL AGONISTS AND ANTAGONISTS OF INTERLEUKIN-2 |